Stocks

Korro Bio KRRO

Health care sectorNasdaq

What to see in Korro Bio now

Is Wall Street adding or cutting?+8

107 13F filers hold it · +8 against the quarter before · shares held +17.8%

Holdings of 06/30
Is stock about to come to market?$764.2K

$764.2K of planned sales filed in 30 days · 0.4% of the units outstanding

Filed 09/14
Who bought more than 5%?4.9%

Atlas Venture Fund XI holds 4.9%

Filed 08/04

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, Massachusetts
Fiscal year end
12/31
Next earnings
11/05, estimated
  • $764.2K of planned sales filed in 30 days · 0.4% of the units outstandingFiled 09/14

Insider trades

Trade type
Open-market sale10b5-1 plan06/2406/2440,679 sh$14.60$593,913.4−4.9%
Open-market sale10b5-1 plan06/2406/24666 sh$14.98$9,976.68−0.1%
Open-market sale10b5-1 plan06/2406/246,979 sh$14.60$101,893.4−4.0%
Open-market sale10b5-1 plan06/2406/24114 sh$14.98$1,707.72−0.1%
Open-market sale10b5-1 plan06/2306/24101,579 sh$14.25$1,447,500.75−10.8%
All insider trades in Korro Bio

Planned sales

Korro BioKRRO10b5-1 plan
31,888 sh$440,373.2809/14Filed 09/14
Korro BioKRRO10b5-1 plan
6,602 sh$91,173.6209/14Filed 09/14
Korro BioKRRO10b5-1 plan
8,450 sh$110,35709/11Filed 09/11
Korro BioKRRO10b5-1 plan
1,750 sh$22,85509/11Filed 09/11
Korro BioKRRO10b5-1 plan
5 sh$68.5809/11Filed 09/11
Korro BioKRRO10b5-1 plan
6 sh$81.6209/09Filed 09/09
Korro BioKRRO10b5-1 plan
7,347 sh$99,285.5209/08Filed 09/08
Korro BioKRRO10b5-1 plan
249 sh$3,418.7708/26Filed 08/26
Korro BioKRRO10b5-1 plan
51 sh$700.2308/26Filed 08/26
Korro BioKRRO10b5-1 plan
23,584 sh$311,780.4808/19Filed 08/19
All planned sales of Korro Bio

26-week trading